Team:MIT mammalian Standard

From 2010.igem.org

(Difference between revisions)
 
(18 intermediate revisions not shown)
Line 25: Line 25:
<ul>
<ul>
                         <li><a href="https://2010.igem.org/Team:MIT_toggle">Overview</a></li>
                         <li><a href="https://2010.igem.org/Team:MIT_toggle">Overview</a></li>
 +
                        <li><a href="https://2010.igem.org/Team:MIT_tmodel">Modelling</a></li>
<li><a href="https://2010.igem.org/Team:MIT_tconst">Toggle Construction</a></li>
<li><a href="https://2010.igem.org/Team:MIT_tconst">Toggle Construction</a></li>
-
<li><a href="#">Characterization</a></li>
+
<li><a href="https://2010.igem.org/Team:MIT_composite">Characterization</a></li>
</ul>
</ul>
</dd>
</dd>
Line 42: Line 43:
</ul>
</ul>
</dd>
</dd>
 +
</dl>
 +
<dl id="specialnav">
<dt><b>Mammalian</b></dt>
<dt><b>Mammalian</b></dt>
Line 49: Line 52:
<li><a href="https://2010.igem.org/Team:MIT_mammalian_Standard">New Mammalian Standard </a></li>
<li><a href="https://2010.igem.org/Team:MIT_mammalian_Standard">New Mammalian Standard </a></li>
                         <li><a href="https://2010.igem.org/Team:MIT_mammalian_Circuit">Circuit Design</a></li>
                         <li><a href="https://2010.igem.org/Team:MIT_mammalian_Circuit">Circuit Design</a></li>
-
<li><a href="https://2010.igem.org/Team:MIT_mammalian_Experiments"> Touchpad Experiments</a></li>
+
<li><a href="https://2010.igem.org/Team:MIT_mammalian_Mechanosensation"> Mechanosensation</a></li>
 +
<li><a href="https://2010.igem.org/Team:MIT_mammalian_Bone"> Bone Formation</a></li>
 +
<li><a href="https://2010.igem.org/Team:MIT_mammalian_Switch"> Synthetic Switch</a></li>
</ul>
</ul>
Line 58: Line 63:
<div id="unique" style="padding:0px; font-size: 14px; border: 1px solid black; margin:0px; background-color:transparent;">
<div id="unique" style="padding:0px; font-size: 14px; border: 1px solid black; margin:0px; background-color:transparent;">
-
<table width=650px style="background-color: white; margin-top:5px; padding: 10px;"><tr><td><div class="bodybaby">Motivation </div></td>
+
<table width=650px style="background-color: white; margin-top:5px; padding: 10px;"><tr><td><div class="bodybaby">New Mammalian Assembly Standard </div></td>
<tr><td>
<tr><td>
Mammalian promoters are difficult to biobrick. They're several kB in length, much longer then their prokaryotic counterparts. This means they're likely to contain most restriction sites used in biobrick cloning. It's difficult to avoid this by changing the promoter sequence; single base pair mutations often alter or abolish the desired function of the promoter. To get around this issue, we've created a new standardization for cloning in mammalian cells, based on the Invitrogen Gateway (c) cloning system.  <A HREF="https://static.igem.org/mediawiki/2010/3/3e/Mammoblock_RFC_Draft.pdf">Read our full 'MammoBlock' standardization proposal</A>  
Mammalian promoters are difficult to biobrick. They're several kB in length, much longer then their prokaryotic counterparts. This means they're likely to contain most restriction sites used in biobrick cloning. It's difficult to avoid this by changing the promoter sequence; single base pair mutations often alter or abolish the desired function of the promoter. To get around this issue, we've created a new standardization for cloning in mammalian cells, based on the Invitrogen Gateway (c) cloning system.  <A HREF="https://static.igem.org/mediawiki/2010/3/3e/Mammoblock_RFC_Draft.pdf">Read our full 'MammoBlock' standardization proposal</A>  
<br><br>
<br><br>
-
Gateway (c) is a fast and reliable way to create expression vectors for mammalian cells. It fulfills the same function as restriction cloning in the Biobrick standardization - it allows us to combine vectors with different 'parts' to create a whole 'circuit'. But the actual mechanism is vastly different from restriction cloning. Gateway uses recombination enzymes to combine multiple vectors, a one-step process that avoids the laborious digestion and ligation steps involved in restriction cloning.
+
<table><tr><td>
-
<br> <br>
+
<a href="https://static.igem.org/mediawiki/2010/e/ed/Gateway_image.tiff" class="thickbox" title="Multi-site LR Gateway Reaction"><img src="https://static.igem.org/mediawiki/2010/e/ed/Gateway_image.tiff" width=300px></a></td><td>
 +
Gateway (c) is a fast and reliable way to create expression vectors for mammalian cells. It fulfills the same function as restriction cloning in the Biobrick standardization - it allows us to combine vectors with different 'parts' to create a whole 'circuit'. But the actual mechanism is vastly different from restriction cloning. Gateway uses recombination enzymes to combine multiple vectors, a one-step process that avoids the laborious digestion and ligation steps involved in restriction cloning.</td></tr></table>
 +
<br>
<b>Cloning Process Overview</b>
<b>Cloning Process Overview</b>
 +
<br>
 +
We start out by cloning all the genes and promoters needed into pENTR vectors; the pENTR vectors contain restriction and recombination sites, so either cloning method can be used to insert the target DNA into the vectors. The next step is to combine pENTR vectors containing the relevant gene and promoter with a pDEST vector containing a lentiviral origin of replication. Gateway cloning allows us to avoid laborious digestion and ligation steps in favor of a faster, more efficient method. To obtain the expression vector, we combine all three plasmids in a recombination reaction; the step takes 12-16 hours total and yields remarkably reliable products.
<br><br>
<br><br>
-
We start out by cloning all the genes and promoters needed into pENTR vectors; the pENTR vectors contain restriction and recombination sites, so either cloning method can be used to insert the target DNA into the vectors. The next step is to combine pENTR vectors containing the relevant gene and promoter with a pDEST vector containing a lentiviral origin of replication. Gateway cloning allows us to avoid laborious digestion and ligation steps in favor a faster, more efficient method. To obtain the expression vector, we combine all three plasmids in a recombination reaction; the step takes 12-16 hours total and yields remarkably reliable products.
 
-
<br> <br>
 
<b>Our Contribution</b>
<b>Our Contribution</b>
-
<br><br>
+
<br>
We are in the process of adding two new backbones to the registry; pENTRL4R1 is a backbone for promoter parts (see map below). The location of the attL4 and attR1 recombination sites place the promoter in front of the gene of interest during Gateway recombination. This construct contains a TRE-inducible promoter between the recombination sites.  
We are in the process of adding two new backbones to the registry; pENTRL4R1 is a backbone for promoter parts (see map below). The location of the attL4 and attR1 recombination sites place the promoter in front of the gene of interest during Gateway recombination. This construct contains a TRE-inducible promoter between the recombination sites.  
-
 
+
<br>
-
<a href="https://static.igem.org/mediawiki/2010/0/0b/L4_TRE_R1_image.jpg" class="thickbox" title="MammoBlock Promoter Backbone"><img src="https://static.igem.org/mediawiki/2010/0/0b/L4_TRE_R1_image.jpg" width=400px></a>
+
<center>
 +
<a href="https://static.igem.org/mediawiki/2010/0/0b/L4_TRE_R1_image.jpg" class="thickbox" title="MammoBlock Promoter Backbone"><img src="https://static.igem.org/mediawiki/2010/0/0b/L4_TRE_R1_image.jpg" width=400px></a></center>
 +
<br>
 +
The second backbone designed to support gene 'parts'. It contains attL1 and attL2 recombination sites flanking the gene of interest.
 +
<br>
 +
<center>
 +
<a href="https://static.igem.org/mediawiki/2010/3/33/L1_EGFP_L2_image.jpg" class="thickbox" title="MammoBlock Gene Backbone"><img src="https://static.igem.org/mediawiki/2010/3/33/L1_EGFP_L2_image.jpg" width=400px></a></center>
</td>
</td>

Latest revision as of 01:07, 28 October 2010

Mammalian
New Mammalian Assembly Standard
Mammalian promoters are difficult to biobrick. They're several kB in length, much longer then their prokaryotic counterparts. This means they're likely to contain most restriction sites used in biobrick cloning. It's difficult to avoid this by changing the promoter sequence; single base pair mutations often alter or abolish the desired function of the promoter. To get around this issue, we've created a new standardization for cloning in mammalian cells, based on the Invitrogen Gateway (c) cloning system. Read our full 'MammoBlock' standardization proposal

Gateway (c) is a fast and reliable way to create expression vectors for mammalian cells. It fulfills the same function as restriction cloning in the Biobrick standardization - it allows us to combine vectors with different 'parts' to create a whole 'circuit'. But the actual mechanism is vastly different from restriction cloning. Gateway uses recombination enzymes to combine multiple vectors, a one-step process that avoids the laborious digestion and ligation steps involved in restriction cloning.

Cloning Process Overview
We start out by cloning all the genes and promoters needed into pENTR vectors; the pENTR vectors contain restriction and recombination sites, so either cloning method can be used to insert the target DNA into the vectors. The next step is to combine pENTR vectors containing the relevant gene and promoter with a pDEST vector containing a lentiviral origin of replication. Gateway cloning allows us to avoid laborious digestion and ligation steps in favor of a faster, more efficient method. To obtain the expression vector, we combine all three plasmids in a recombination reaction; the step takes 12-16 hours total and yields remarkably reliable products.

Our Contribution
We are in the process of adding two new backbones to the registry; pENTRL4R1 is a backbone for promoter parts (see map below). The location of the attL4 and attR1 recombination sites place the promoter in front of the gene of interest during Gateway recombination. This construct contains a TRE-inducible promoter between the recombination sites.

The second backbone designed to support gene 'parts'. It contains attL1 and attL2 recombination sites flanking the gene of interest.

Retrieved from "http://2010.igem.org/Team:MIT_mammalian_Standard"